The Antiherpetic Drug Acyclovir Inhibits HIV Replication and Selects the V75I Reverse Transcriptase Multidrug Resistance Mutation
Open Access
- 1 November 2008
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 283 (46) , 31289-31293
- https://doi.org/10.1074/jbc.c800188200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Acyclovir Is Activated into a HIV-1 Reverse Transcriptase Inhibitor in Herpesvirus-Infected Human TissuesCell Host & Microbe, 2008
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugsNature Medicine, 2008
- Effect of Herpes Simplex Suppression on Incidence of HIV among Women in TanzaniaNew England Journal of Medicine, 2008
- Mechanistic Insights into the Role of Val75 of HIV-1 Reverse Transcriptase in Misinsertion and Mispair Extension Fidelity of DNA SynthesisJournal of Molecular Biology, 2007
- The HBV Drug Entecavir — Effects on HIV-1 Replication and ResistanceNew England Journal of Medicine, 2007
- Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 + T CellsJournal of Virology, 2006
- Persistence of Wild-Type Virus and Lack of Temporal Structure in the Latent Reservoir for Human Immunodeficiency Virus Type 1 in Pediatric Patients with Extensive Antiretroviral ExposureJournal of Virology, 2002
- Herpes Simplex Virus Type 2 Shedding in Human Immunodeficiency Virus—Negative Men Who Have Sex with Men: Frequency, Patterns, and Risk FactorsClinical Infectious Diseases, 2000
- Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of DefectsScience, 1996
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990